ArticleSubstance use & addiction journal2026
Brief Report: Naloxone Decline Among African American Kentuckians.
Article in Substance use & addiction journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundOpioid-involved overdose fatalities among African Americans continue to rise. The current study examines African Americans who reported use of opioids in the past 6 months and declined overdose education and free naloxone.
methodEligible participants included African American Kentuckians who used opioids in the past 6 months and consented to a larger study examining their opioid use. This paper qualitatively explored their reasons for declining overdose education and naloxone using an adjusted and inductive application of structural tabular thematic analysis.
resultsOut of 588 participants, 70 (12%) declined naloxone: the most cited reason for declining naloxone was already possessing the medication. Additional reasons range from not needing or wanting naloxone to no longer using opioids.
conclusionsThe findings suggest that African Americans' hesitancy to carry naloxone can be due to pervasive structural issues. Despite these findings, there remain disproportionate drug treatment rates and mortality from overdose among African Americans.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.